Intralymphatic chemotherapy using a hyaluronan-cisplatin conjugate.

The Journal of Surgical Research
Shuang CaiM Laird Forrest

Abstract

Breast cancers typically spread to regional lymph nodes once they disseminate from the primary tumor, thus adequate evaluation and treatment of the axillary lymph nodes is paramount in early stage disease. One significant problem with current therapy is the side effects chemotherapy agents create systemically, either alone or in combination. The purpose of this study is to determine whether lymphatically targeted cisplatin carriers will increase the localized dose in lymphatic metastases without systemic toxicities. Hyaluronan (HA) is a highly biocompatible polymer that follows lymphatic drainage from the interstitial spaces. We formed complexes of HA and cisplatin by non-covalent conjugation. Complexes were injected subcutaneously into the upper mammary fat pad of female rats, and the tissue distribution determined. Cisplatin-HA contained up to 0.25 w/w of Pt and released drug with a half-life of 10 h in saline. Cisplatin-HA conjugates had high anti-tumor activity in vitro similar to the free drug: cisplatin-HA IC50 7 microg/mL in MCF7 and MDA-MB-231 human breast cancer cells (free cisplatin IC50 7 microg/mL). Cisplatin-HA conjugates were well tolerated in rodents with no signs of injection site morbidity or major organ toxici...Continue Reading

References

Jul 1, 1994·The Journal of Experimental Medicine·A BartolazziI Stamenkovic
May 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A DietrichJ C Simon
Dec 22, 1999·International Journal of Cancer. Journal International Du Cancer·J T HartmannC Bokemeyer
Feb 13, 2001·The Journal of Investigative Dermatology·T AhrensJ C Simon
Nov 3, 2006·Cancer Research·Martin Götte, George W Yip
Aug 4, 2007·Journal of Pharmaceutical Sciences·Young-Il JeongShin Jung

❮ Previous
Next ❯

Citations

Mar 12, 2010·Pharmaceutical Research·Bing GuWeiyue Lu
Aug 9, 2013·International Journal of Nanomedicine·Arshad Ali KhanYusrida Darwis
Nov 28, 2012·American Journal of Veterinary Research·Rachel O VenableM Laird Forrest
Mar 20, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Silvia ArpiccoFranco Dosio
May 29, 2012·Journal of Cancer Research and Clinical Oncology·Murat ZorMurat Dayanc
Mar 29, 2014·Drug Delivery·Shambhu Dokania, Amita K Joshi
Oct 17, 2015·Drug Development and Industrial Pharmacy·Yanan LiAmmar Ouahab
Dec 20, 2013·Expert Opinion on Drug Delivery·Indu SinghRamakrishna Sistla
Jun 4, 2014·Journal of Drug Targeting·Shuang CaiM Laird Forrest
Jul 1, 2009·Expert Opinion on Drug Delivery·Yumei XieM Laird Forrest
Nov 7, 2015·Advanced Drug Delivery Reviews·Jiurong LiangPaul W Noble
Nov 26, 2015·Advanced Drug Delivery Reviews·Franco DosioElias Fattal
Feb 6, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Xiaopin DuanWenbin Lin
May 2, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Taryn R BagbyM Laird Forrest
Sep 3, 2011·International Journal of Pharmaceutics·Elaine L FergusonDavid W Thomas
Jun 21, 2011·Advanced Drug Delivery Reviews·Stephanie M CohenMark S Cohen
Jul 2, 2011·Advanced Drug Delivery Reviews·Satish K NuneM Laird Forrest
Jun 28, 2011·Advanced Drug Delivery Reviews·Jennifer D McAllaster, Mark S Cohen
Jan 1, 2009·Seminars in Thoracic and Cardiovascular Surgery·Stefan S KachalaPrasad S Adusumilli
Dec 23, 2015·The Laryngoscope·Michael W SimMark S Cohen
Oct 17, 2015·Nature Reviews. Drug Discovery·Natalie L TrevaskisChristopher J H Porter
Aug 6, 2013·Journal of Biomedical Materials Research. Part B, Applied Biomaterials·Jacob H SwetIain H McKillop
May 15, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Steven T ProulxMichael Detmar
May 8, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Gemma M RyanChristopher J H Porter
May 7, 2016·International Journal of Biological Macromolecules·Rasha M Abdel-RahmanJ Jancar
Sep 1, 2016·American Journal of Veterinary Research·Shuang CaiM Laird Forrest
Feb 23, 2017·ACS Applied Materials & Interfaces·Weiqi Zhang, Ching-Hsuan Tung
Feb 23, 2010·Molecular BioSystems·John GaffneyMark Slevin
Dec 22, 2016·Chemical Communications : Chem Comm·Weiqi ZhangChing-Hsuan Tung

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Bladder Carcinoma In Situ

Bladder Carcinoma In Situ is a superficial bladder cancer that occurs on the surface layer of the bladder. Discover the latest research on this precancerous condition in this feed.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.